TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiovascular Risk
Study findings from G. Grassi et al broaden understanding of cardiovascular risk
June 9th, 2009
"Several lines of evidence show that metabolic syndrome represents an important therapeutic challenge for the forthcoming years," scientists writing in the journal Blood Pressure report. "This is because of the epidemic burden of this multifaceted disease, the adverse impact on cardiovascular risk, as well as the problems posed in its management. This paper will provide an up-to-date report on metabolic syndrome and cardiometabolic risk, focusing in particular on the epidemiological profile of the disease, the impact on risk profile and target organ damage as well as some of the main pathophysiological features of the condition," wrote G. Grassi and...
Source: TB & Outbreaks Week (2009-06-09)
|
